Corvus Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRVS and other ETFs, options, and stocks.About CRVS
Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor.
CRVS Key Statistics
Stock Snapshot
Corvus Pharmaceuticals(CRVS) stock is priced at $12.53, giving the company a market capitalization of 1.05B. It carries a P/E multiple of -25.96.
On 2026-05-15, Corvus Pharmaceuticals(CRVS) stock moved within a range of $12.47 to $13.57. With shares now at $12.53, the stock is trading +0.5% above its intraday low and -7.7% below the session's peak.
Trading activity shows a volume of 1.29M, compared to an average daily volume of 1.41M.
Over the past 52 weeks, Corvus Pharmaceuticals(CRVS) stock has traded between a high of $26.95 and a low of $3.38.
Over the past 52 weeks, Corvus Pharmaceuticals(CRVS) stock has traded between a high of $26.95 and a low of $3.38.
CRVS News
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Analyst ratings
100%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.